China Dihydroartemisinin Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Dihydroartemisinin market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Dihydroartemisinin market. Detailed analysis of key players, along with key growth strategies adopted by Dihydroartemisinin industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Guilin Pharmaceutical

    • KPC Pharmaceuticals

    • Shanghai Natural Bio-engineering Co

    • Kerui Nanhai Pharmaceutical

    • Botanical Extracts EPZ Ltd

    • Guangxi Xiancaotang Pharmaceutical

    • Novanat Bioresource

    • Sanofi

    By Type:

    • Pharmaceutical Grade

    • Industrial Grade

    By End-User:

    • Malaria Treatment

    • Scientific Research

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Dihydroartemisinin Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Dihydroartemisinin Market Size and Growth Rate of Pharmaceutical Grade from 2016 to 2027

    • 1.3.2 China Dihydroartemisinin Market Size and Growth Rate of Industrial Grade from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Dihydroartemisinin Market Size and Growth Rate of Malaria Treatment from 2016 to 2027

    • 1.4.2 China Dihydroartemisinin Market Size and Growth Rate of Scientific Research from 2016 to 2027

    • 1.4.3 China Dihydroartemisinin Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Dihydroartemisinin Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Dihydroartemisinin by Major Types

    • 3.4.1 Market Size and Growth Rate of Pharmaceutical Grade

    • 3.4.2 Market Size and Growth Rate of Industrial Grade

    4 Segmentation of Dihydroartemisinin Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Dihydroartemisinin by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Dihydroartemisinin in Malaria Treatment

    • 4.4.2 Market Size and Growth Rate of Dihydroartemisinin in Scientific Research

    • 4.4.3 Market Size and Growth Rate of Dihydroartemisinin in Others

    5 Market Analysis by Regions

    • 5.1 China Dihydroartemisinin Production Analysis by Regions

    • 5.2 China Dihydroartemisinin Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Dihydroartemisinin Landscape Analysis

    • 6.1 North China Dihydroartemisinin Landscape Analysis by Major Types

    • 6.2 North China Dihydroartemisinin Landscape Analysis by Major End-Users

    7 Central China Dihydroartemisinin Landscape Analysis

    • 7.1 Central China Dihydroartemisinin Landscape Analysis by Major Types

    • 7.2 Central China Dihydroartemisinin Landscape Analysis by Major End-Users

    8 South China Dihydroartemisinin Landscape Analysis

    • 8.1 South China Dihydroartemisinin Landscape Analysis by Major Types

    • 8.2 South China Dihydroartemisinin Landscape Analysis by Major End-Users

    9 East China Dihydroartemisinin Landscape Analysis

    • 9.1 East China Dihydroartemisinin Landscape Analysis by Major Types

    • 9.2 East China Dihydroartemisinin Landscape Analysis by Major End-Users

    10 Northeast China Dihydroartemisinin Landscape Analysis

    • 10.1 Northeast China Dihydroartemisinin Landscape Analysis by Major Types

    • 10.2 Northeast China Dihydroartemisinin Landscape Analysis by Major End-Users

    11 Southwest China Dihydroartemisinin Landscape Analysis

    • 11.1 Southwest China Dihydroartemisinin Landscape Analysis by Major Types

    • 11.2 Southwest China Dihydroartemisinin Landscape Analysis by Major End-Users

    12 Northwest China Dihydroartemisinin Landscape Analysis

    • 12.1 Northwest China Dihydroartemisinin Landscape Analysis by Major Types

    • 12.2 Northwest China Dihydroartemisinin Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Guilin Pharmaceutical

      • 13.1.1 Guilin Pharmaceutical Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 KPC Pharmaceuticals

      • 13.2.1 KPC Pharmaceuticals Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Shanghai Natural Bio-engineering Co

      • 13.3.1 Shanghai Natural Bio-engineering Co Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Kerui Nanhai Pharmaceutical

      • 13.4.1 Kerui Nanhai Pharmaceutical Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Botanical Extracts EPZ Ltd

      • 13.5.1 Botanical Extracts EPZ Ltd Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Guangxi Xiancaotang Pharmaceutical

      • 13.6.1 Guangxi Xiancaotang Pharmaceutical Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Novanat Bioresource

      • 13.7.1 Novanat Bioresource Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Sanofi

      • 13.8.1 Sanofi Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Dihydroartemisinin Market Size and Growth Rate of Pharmaceutical Grade from 2016 to 2027

    • Figure China Dihydroartemisinin Market Size and Growth Rate of Industrial Grade from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Dihydroartemisinin Market Size and Growth Rate of Malaria Treatment from 2016 to 2027

    • Figure China Dihydroartemisinin Market Size and Growth Rate of Scientific Research from 2016 to 2027

    • Figure China Dihydroartemisinin Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Dihydroartemisinin Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Dihydroartemisinin Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Dihydroartemisinin

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Dihydroartemisinin by Different Types from 2016 to 2027

    • Table Consumption Share of Dihydroartemisinin by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Pharmaceutical Grade

    • Figure Market Size and Growth Rate of Industrial Grade

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Dihydroartemisinin by Different End-Users from 2016 to 2027

    • Table Consumption Share of Dihydroartemisinin by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Malaria Treatment

    • Figure Market Size and Growth Rate of Scientific Research

    • Figure Market Size and Growth Rate of Others

    • Table China Dihydroartemisinin Production by Regions

    • Table China Dihydroartemisinin Production Share by Regions

    • Figure China Dihydroartemisinin Production Share by Regions in 2016

    • Figure China Dihydroartemisinin Production Share by Regions in 2021

    • Figure China Dihydroartemisinin Production Share by Regions in 2027

    • Table China Dihydroartemisinin Consumption by Regions

    • Table China Dihydroartemisinin Consumption Share by Regions

    • Figure China Dihydroartemisinin Consumption Share by Regions in 2016

    • Figure China Dihydroartemisinin Consumption Share by Regions in 2021

    • Figure China Dihydroartemisinin Consumption Share by Regions in 2027

    • Table North China Dihydroartemisinin Consumption by Types from 2016 to 2027

    • Table North China Dihydroartemisinin Consumption Share by Types from 2016 to 2027

    • Figure North China Dihydroartemisinin Consumption Share by Types in 2016

    • Figure North China Dihydroartemisinin Consumption Share by Types in 2021

    • Figure North China Dihydroartemisinin Consumption Share by Types in 2027

    • Table North China Dihydroartemisinin Consumption by End-Users from 2016 to 2027

    • Table North China Dihydroartemisinin Consumption Share by End-Users from 2016 to 2027

    • Figure North China Dihydroartemisinin Consumption Share by End-Users in 2016

    • Figure North China Dihydroartemisinin Consumption Share by End-Users in 2021

    • Figure North China Dihydroartemisinin Consumption Share by End-Users in 2027

    • Table Central China Dihydroartemisinin Consumption by Types from 2016 to 2027

    • Table Central China Dihydroartemisinin Consumption Share by Types from 2016 to 2027

    • Figure Central China Dihydroartemisinin Consumption Share by Types in 2016

    • Figure Central China Dihydroartemisinin Consumption Share by Types in 2021

    • Figure Central China Dihydroartemisinin Consumption Share by Types in 2027

    • Table Central China Dihydroartemisinin Consumption by End-Users from 2016 to 2027

    • Table Central China Dihydroartemisinin Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Dihydroartemisinin Consumption Share by End-Users in 2016

    • Figure Central China Dihydroartemisinin Consumption Share by End-Users in 2021

    • Figure Central China Dihydroartemisinin Consumption Share by End-Users in 2027

    • Table South China Dihydroartemisinin Consumption by Types from 2016 to 2027

    • Table South China Dihydroartemisinin Consumption Share by Types from 2016 to 2027

    • Figure South China Dihydroartemisinin Consumption Share by Types in 2016

    • Figure South China Dihydroartemisinin Consumption Share by Types in 2021

    • Figure South China Dihydroartemisinin Consumption Share by Types in 2027

    • Table South China Dihydroartemisinin Consumption by End-Users from 2016 to 2027

    • Table South China Dihydroartemisinin Consumption Share by End-Users from 2016 to 2027

    • Figure South China Dihydroartemisinin Consumption Share by End-Users in 2016

    • Figure South China Dihydroartemisinin Consumption Share by End-Users in 2021

    • Figure South China Dihydroartemisinin Consumption Share by End-Users in 2027

    • Table East China Dihydroartemisinin Consumption by Types from 2016 to 2027

    • Table East China Dihydroartemisinin Consumption Share by Types from 2016 to 2027

    • Figure East China Dihydroartemisinin Consumption Share by Types in 2016

    • Figure East China Dihydroartemisinin Consumption Share by Types in 2021

    • Figure East China Dihydroartemisinin Consumption Share by Types in 2027

    • Table East China Dihydroartemisinin Consumption by End-Users from 2016 to 2027

    • Table East China Dihydroartemisinin Consumption Share by End-Users from 2016 to 2027

    • Figure East China Dihydroartemisinin Consumption Share by End-Users in 2016

    • Figure East China Dihydroartemisinin Consumption Share by End-Users in 2021

    • Figure East China Dihydroartemisinin Consumption Share by End-Users in 2027

    • Table Northeast China Dihydroartemisinin Consumption by Types from 2016 to 2027

    • Table Northeast China Dihydroartemisinin Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Dihydroartemisinin Consumption Share by Types in 2016

    • Figure Northeast China Dihydroartemisinin Consumption Share by Types in 2021

    • Figure Northeast China Dihydroartemisinin Consumption Share by Types in 2027

    • Table Northeast China Dihydroartemisinin Consumption by End-Users from 2016 to 2027

    • Table Northeast China Dihydroartemisinin Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Dihydroartemisinin Consumption Share by End-Users in 2016

    • Figure Northeast China Dihydroartemisinin Consumption Share by End-Users in 2021

    • Figure Northeast China Dihydroartemisinin Consumption Share by End-Users in 2027

    • Table Southwest China Dihydroartemisinin Consumption by Types from 2016 to 2027

    • Table Southwest China Dihydroartemisinin Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Dihydroartemisinin Consumption Share by Types in 2016

    • Figure Southwest China Dihydroartemisinin Consumption Share by Types in 2021

    • Figure Southwest China Dihydroartemisinin Consumption Share by Types in 2027

    • Table Southwest China Dihydroartemisinin Consumption by End-Users from 2016 to 2027

    • Table Southwest China Dihydroartemisinin Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Dihydroartemisinin Consumption Share by End-Users in 2016

    • Figure Southwest China Dihydroartemisinin Consumption Share by End-Users in 2021

    • Figure Southwest China Dihydroartemisinin Consumption Share by End-Users in 2027

    • Table Northwest China Dihydroartemisinin Consumption by Types from 2016 to 2027

    • Table Northwest China Dihydroartemisinin Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Dihydroartemisinin Consumption Share by Types in 2016

    • Figure Northwest China Dihydroartemisinin Consumption Share by Types in 2021

    • Figure Northwest China Dihydroartemisinin Consumption Share by Types in 2027

    • Table Northwest China Dihydroartemisinin Consumption by End-Users from 2016 to 2027

    • Table Northwest China Dihydroartemisinin Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Dihydroartemisinin Consumption Share by End-Users in 2016

    • Figure Northwest China Dihydroartemisinin Consumption Share by End-Users in 2021

    • Figure Northwest China Dihydroartemisinin Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Guilin Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guilin Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Guilin Pharmaceutical

    • Figure Revenue and Market Share Analysis of Guilin Pharmaceutical

    • Table Product and Service Introduction of Guilin Pharmaceutical

    • Table Company Profile and Development Status of KPC Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of KPC Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of KPC Pharmaceuticals

    • Figure Revenue and Market Share Analysis of KPC Pharmaceuticals

    • Table Product and Service Introduction of KPC Pharmaceuticals

    • Table Company Profile and Development Status of Shanghai Natural Bio-engineering Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Natural Bio-engineering Co

    • Figure Sales and Growth Rate Analysis of Shanghai Natural Bio-engineering Co

    • Figure Revenue and Market Share Analysis of Shanghai Natural Bio-engineering Co

    • Table Product and Service Introduction of Shanghai Natural Bio-engineering Co

    • Table Company Profile and Development Status of Kerui Nanhai Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kerui Nanhai Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Kerui Nanhai Pharmaceutical

    • Figure Revenue and Market Share Analysis of Kerui Nanhai Pharmaceutical

    • Table Product and Service Introduction of Kerui Nanhai Pharmaceutical

    • Table Company Profile and Development Status of Botanical Extracts EPZ Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Botanical Extracts EPZ Ltd

    • Figure Sales and Growth Rate Analysis of Botanical Extracts EPZ Ltd

    • Figure Revenue and Market Share Analysis of Botanical Extracts EPZ Ltd

    • Table Product and Service Introduction of Botanical Extracts EPZ Ltd

    • Table Company Profile and Development Status of Guangxi Xiancaotang Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guangxi Xiancaotang Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Guangxi Xiancaotang Pharmaceutical

    • Figure Revenue and Market Share Analysis of Guangxi Xiancaotang Pharmaceutical

    • Table Product and Service Introduction of Guangxi Xiancaotang Pharmaceutical

    • Table Company Profile and Development Status of Novanat Bioresource

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novanat Bioresource

    • Figure Sales and Growth Rate Analysis of Novanat Bioresource

    • Figure Revenue and Market Share Analysis of Novanat Bioresource

    • Table Product and Service Introduction of Novanat Bioresource

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.